Weinberg Jonathan 4

What Happened
Jonathan Weinberg, General Counsel of Evolent Health (EVH), was granted 43,055 restricted stock units (RSUs) on July 1, 2026 (reported as an award, code A). On the same date, 2,650 shares were withheld to satisfy tax withholding (code F) at $5.74 per share, totaling $15,211. The RSU grant is compensation — not an open‑market purchase or sale.

Key Details

• Transaction dates: July 1, 2026 (award and tax withholding); Form 4 filed July 6, 2026. The filing appears late relative to the usual two-business-day Form 4 deadline.
• Award: 43,055 RSUs granted (price reported $0.00 as typical for RSUs).
• Tax withholding: 2,650 shares withheld at $5.74/share = $15,211 (reported as a disposition under code F).
• Vesting: 34% on July 1, 2027; 33% on July 1, 2028; 33% on July 1, 2029 (per filing).
• Plan and approvals: This tranche was part of the annual award cycle; a first portion was granted March 2, 2026, and shareholders approved additional shares for the omnibus plan on June 4, 2026. The award includes RSUs from previously reported awards.
• Shares owned after the transaction: Not provided in the excerpt of the filing.
• Transaction codes explained: A = award/grant; F = shares withheld to satisfy tax withholding upon vesting (cashless-type withholding).

Context
RSU grants are a form of compensation intended to align executives with shareholder interests over time; they vest in future years rather than representing an immediate market purchase. The small number of shares withheld for taxes reduces the net increase in holdings and is routine. This filing reports a compensation grant rather than a directional insider trade.